Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice
- PMID: 309437
- PMCID: PMC422059
- DOI: 10.1128/iai.21.3.729-737.1978
Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice
Abstract
Mice depleted of T-lymphocytes by thymectomy and irradiation (TXB) and immunologically competent mice were compared for gross and histological pathology as well as immune responses after cutaneous and/or intravenous challenge with Candida albicans. In response to a first cutaneous inoculation with viable Candida, TXB, sham-operated (SXB), and unmanipulated (normal) mice, all developed lesions of comparable size, duration, and histopathology. When challenged a second time cutaneously, normal and SXB mice developed lesions which were greatly increased in size when compared with those produced by a first cutaneous infection, whereas TXB mice developed lesions comparable in size to those initiated by the first infection. Histologically, the first and second lesions in all animals were acute abscesses predominantly comprised of polymorphonuclear leukocytes. The larger second lesions in SXB and normal mice were accompanied by detectable circulating antibody and by delayed hypersensitivity. Neither circulating antibody nor delayed hypersensitivity were stimulated in the TXB mice. When challenged intravenously, all previously uninfected mice, regardless of T-cell status, were equally susceptible to C. albicans. Contrary to SXB or normal mice, however, TXB mice which had been infected cutaneously were not more resistant to a subsequent intravenous challenge as judged by 6-week survival. The results suggest that T-cells do not play a significant role in innate resistance of mice to systemic candidiasis, but that such cells are important in the development of acquired resistance.
Similar articles
-
Effects of cyclophosphamide on murine candidiasis.Infect Immun. 1980 Feb;27(2):376-86. doi: 10.1128/iai.27.2.376-386.1980. Infect Immun. 1980. PMID: 6991413 Free PMC article.
-
Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.Infect Immun. 1978 Feb;19(2):499-509. doi: 10.1128/iai.19.2.499-509.1978. Infect Immun. 1978. PMID: 344213 Free PMC article.
-
Studies of experimental candidiasis in T-cell-deficient mice.Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jun;265(1-2):203-9. doi: 10.1016/s0176-6724(87)80167-0. Zentralbl Bakteriol Mikrobiol Hyg A. 1987. PMID: 3314257
-
[Current state of immunology of visceral mycoses].Vestn Dermatol Venerol. 1978 Nov;(11):38-43. Vestn Dermatol Venerol. 1978. PMID: 366947 Review. Russian. No abstract available.
-
Production and function of cytokines in natural and acquired immunity to Candida albicans infection.Microbiol Rev. 1995 Dec;59(4):646-72. doi: 10.1128/mr.59.4.646-672.1995. Microbiol Rev. 1995. PMID: 8531890 Free PMC article. Review.
Cited by
-
Evidence for macrophage-mediated protection against lethal Candida albicans infection.Infect Immun. 1986 Feb;51(2):668-74. doi: 10.1128/iai.51.2.668-674.1986. Infect Immun. 1986. PMID: 3943907 Free PMC article.
-
Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex.Immunogenetics. 1987;25(3):200-3. doi: 10.1007/BF00344035. Immunogenetics. 1987. PMID: 2881888
-
Adherence of Candida albicans to tissues from mice with genetic immunodeficiencies.Infect Immun. 1991 Sep;59(9):3069-78. doi: 10.1128/iai.59.9.3069-3078.1991. Infect Immun. 1991. PMID: 1879931 Free PMC article.
-
Effects of cyclophosphamide on murine candidiasis.Infect Immun. 1980 Feb;27(2):376-86. doi: 10.1128/iai.27.2.376-386.1980. Infect Immun. 1980. PMID: 6991413 Free PMC article.
-
Immunity to Candida albicans.Microbiol Rev. 1980 Dec;44(4):660-82. doi: 10.1128/mr.44.4.660-682.1980. Microbiol Rev. 1980. PMID: 7010113 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources